Cartesian Therapeutics, Inc. (RNAC)

6.60 +0.38 (+6.11%) USD  |  NASDAQ  |  May 04, 10:23
More

Cartesian Therapeutics Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for RNAC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Precision BioSciences, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade